Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Quentin Anstee

Newcastle AuthorsTitleYearFull text
Professor Quentin Anstee
Addressing the High and Rising Global Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH): From the Growing Prevalence to Payors' Perspective2025
Professor Quentin Anstee
Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease2025
Professor Quentin Anstee
ECM formation and degradation during fibrosis, repair, and regeneration2025
Professor Quentin Anstee
Efficacy and safety of ervogastat alone and in combination with clesacostat in patients with biopsy-confirmed metabolic dysfunction-associated steatohepatitis and F2–F3 fibrosis( MIRNA): results from the phase 2, randomised, double-blind, double-dummy study2025
Professor Arun Sanyal
Professor Quentin Anstee
Exploration of Multiple Non-Invasive Tests for Assessing Response to Treatment in a Semaglutide Phase 2b Trial in Patients With MASH2025
Professor Quentin Anstee
Hot and cold fibrosis: The role of serum biomarkers to assess immune mechanisms and ECM-cell interactions in human fibrosis2025
Professor Quentin Anstee
Emerita Professor Ann Daly
Dr Olivier Govaere
Insulin-like Growth Factor-1 Reflects Liver Disease Stage and Improves Prediction of Liver-related Mortality2025
Professor Quentin Anstee
Letter to the Editor: Serum Identification of At-Risk MASH: The Metabolomics-Advanced Steatohepatitis Fibrosis Score (MASEF)2025
Professor Quentin Anstee
Modulation of metabolic, inflammatory, and fibrotic pathways by Semaglutide in MASLD2025
Dr Matt Breckons
Professor Luke Vale
Dr Lorraine McSweeney
Professor Quentin Anstee
NASH-CHECK patient-reported outcome instrument: evaluation of content and face validity for patients with metabolic dysfunction–associated steatohepatitis and compensated cirrhosis2025
Professor Quentin Anstee
Precision in Liver Diagnosis: Varied Accuracy Across Subgroups and the Need for Variable Thresholds in Diagnosis of MASLD2025
Professor Quentin Anstee
Real-world work productivity is impaired in people with metabolic dysfunction-associated steatotic liver disease in the USA2025
Professor Quentin Anstee
Response to: Precision in Diagnosis of Liver Fibrosis in MASLD: Machine Learning Based Scores May Be More Accurate Than Conventional NITs2025
Professor Quentin Anstee
Variance Between Clinical Guidance and Real-world Management of Metabolic Dysfunction-associated Steatotic Liver Disease in the United States2025
Professor Arun Sanyal
Professor Pierre Bedossa
Professor Quentin Anstee
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis2024
1234567891011121314151617181920...>>